Cite
Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin.
MLA
Ito, Shin, et al. “Clinical and Microbiological Outcomes in Treatment of Men with Non-Gonococcal Urethritis with a 100-Mg Twice-Daily Dose Regimen of Sitafloxacin.” Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), vol. 18, no. 3, June 2012, pp. 414–18. EBSCOhost, https://doi.org/10.1007/s10156-012-0392-9.
APA
Ito, S., Yasuda, M., Seike, K., Sugawara, T., Tsuchiya, T., Yokoi, S., Nakano, M., & Deguchi, T. (2012). Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 18(3), 414–418. https://doi.org/10.1007/s10156-012-0392-9
Chicago
Ito, Shin, Mitsuru Yasuda, Kensaku Seike, Takashi Sugawara, Tomohiro Tsuchiya, Shigeaki Yokoi, Masahiro Nakano, and Takashi Deguchi. 2012. “Clinical and Microbiological Outcomes in Treatment of Men with Non-Gonococcal Urethritis with a 100-Mg Twice-Daily Dose Regimen of Sitafloxacin.” Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.) 18 (3): 414–18. doi:10.1007/s10156-012-0392-9.